/SONVY

SONVY Stock - Sonova Holding AG

Q: What is the analyst price target for SONVY?

Analyst price target information is not currently available for SONVY.

Q: What is SONVY's market cap?

Market capitalization information is not currently available for SONVY.

Healthcare|Medical - Devices|OTC

$51.67-0.19%

$0.10 (-0.19%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $56.84

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for SONVY

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2021

FY2022

FY2023

FY2024

FY2025

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta1.22

52W High$71.50

52W Low$47.55

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	$3.87B	$3.63B	$3.74B	$3.36B	$2.60B
Gross Profit	$2.78B	$2.62B	$2.59B	$2.42B	$1.84B
Gross Margin	72.0%	72.3%	69.3%	72.0%	70.6%
Operating Income	$691.90M	$669.90M	$761.80M	$785.10M	$559.20M
Net Income	$540.50M	$601.00M	$647.50M	$649.00M	$581.00M
Net Margin	14.0%	16.6%	17.3%	19.3%	22.3%
EPS	$1.81	$2.01	$2.15	$2.08	$1.85

Company Overview

Sonova Holding AG designs, develops, manufactures, and distributes hearing care solutions for adults and children. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The company offers wireless communication products; rechargeable hearing aids; wireless headsets, speech enhanced hearables, audiophile headphones, microphones, and wireless transmission systems; and audiological care services. It also provides hearing instruments under the Phonak, Unitron, and Hansaton brand names; cochlear implants under the Advanced Bionics brand; consumer hearing products under the Sennheiser brand; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton brands. The company sells its products through independent distributors; and provides hearing care services through a network of approximately 3,600 stores and clinics. It operates in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Phonak Holding AG and changed its name to Sonova Holding AG in August 2007. Sonova Holding AG was founded in 1947 and is headquartered in Stäfa, Switzerland.

Visit Website

Rating Distribution

Strong Buy

Buy / Outperform

Hold / Neutral

71%

Sell / Underperform

29%

Analyst Consensus🔴 Bearish

0 Bullish7 Neutral/Bearish

Price Targets

No price targets available

Recent Analyst Actions

Date	Firm	Action	Rating	Price Target
May 17th 2023	JP Morgan	Downgrade	Neutral	-
May 12th 2023	Bernstein	Initiation	Underperform	-
December 12th 2022	Citigroup	Initiation	Sell	-
October 18th 2022	Morgan Stanley	Initiation	Equal Weight	-
October 18th 2022	Credit Suisse	Downgrade	Neutral	-
September 13th 2022	Barclays	Initiation	Overweight	-
August 29th 2022	Deutsche Bank	Downgrade	Hold	-
April 21st 2022	Jefferies	Initiation	Hold	-

Earnings History & Surprises

SONVY

Beat Rate

83%

Last 12 quarters

Avg Surprise

+346.0%

EPS vs Estimate

Beats / Misses

10/2

Last 12 quarters

Latest EPS

$0.90

Q4 2025

EPS Surprise History

Q2 22

+882.4%

$6.14vs$0.63

Q3 22

+407.3%

$4.86vs$0.96

Q2 23

+422.6%

$6.48vs$1.24

Q1 24

+381.6%

$4.46vs$0.93

Q2 24

+462.4%

$6.58vs$1.17

Q4 24

-2.6%

$0.85vs$0.87

Q2 25

+24.8%

$1.71vs$1.37

Q4 25

-8.7%

$0.90vs$0.98

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2026	May 7, 2026	—	—	—	—
Q4 2025	Nov 14, 2025	$0.98	$0.90	-8.7%	✗ MISS
Q2 2025	May 9, 2025	$1.37	$1.71	+24.8%	✓ BEAT
Q4 2024	Nov 19, 2024	$0.87	$0.85	-2.6%	✗ MISS
Q2 2024	May 14, 2024	$1.17	$6.58	+462.4%	✓ BEAT
Q1 2024	Mar 21, 2024	$0.93	$4.46	+381.6%	✓ BEAT
Q2 2023	May 16, 2023	$1.24	$6.48	+422.6%	✓ BEAT
Q3 2022	Sep 30, 2022	$0.96	$4.86	+407.3%	✓ BEAT
Q2 2022	May 17, 2022	$0.63	$6.14	+882.4%	✓ BEAT
Q3 2021	Sep 30, 2021	$1.22	$5.00	+309.8%	✓ BEAT
Q1 2021	Mar 31, 2021	$1.04	$6.32	+507.7%	✓ BEAT
Q3 2020	Sep 30, 2020	$0.52	$3.52	+582.2%	✓ BEAT
Q1 2020	Mar 31, 2020	$0.74	$2.09	+182.1%	✓ BEAT
Q3 2019	Sep 30, 2019	—	$5.50	—	—
Q1 2019	Mar 31, 2019	—	$4.07	—	—
Q3 2018	Sep 30, 2018	—	$2.97	—	—
Q1 2018	Mar 31, 2018	—	$3.63	—	—
Q3 2017	Sep 30, 2017	—	$2.72	—	—
Q1 2017	Mar 31, 2017	—	$3.05	—	—
Q3 2016	Sep 30, 2016	—	$2.36	—	—